BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2146981)

  • 1. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Pizzolo G; Bulian P; Masciarelli M; Feruglio C; Agostini C; Raimondi R; Chisesi T; Semenzato G
    Blood; 1990 Nov; 76(10):2080-5. PubMed ID: 2146981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
    Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
    Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
    Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
    Hoshino S; Oshimi K; Teramura M; Mizoguchi H
    Blood; 1991 Dec; 78(12):3232-40. PubMed ID: 1835892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
    Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
    Yoon HJ; Sugamura K; Loughran TP
    Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes.
    Pandolfi F; Foa R; De Rossi G; Zambello R; Chisesi T; di Celle PF; Migone N; Casorati G; Scarselli E; Ensoli F
    Clin Immunol Immunopathol; 1991 Sep; 60(3):371-83. PubMed ID: 1830831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
    Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the interleukin 2 receptor beta chain (p75) in renal transplantation--applicability of anti-interleukin-2 receptor beta chain monoclonal antibody.
    Niguma T; Sakagami K; Kawamura T; Haisa M; Fujiwara T; Kusaka S; Uda M; Orita K
    Transplantation; 1991 Aug; 52(2):296-302. PubMed ID: 1831304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR; Frey J; Takeshita T; Sugamura K
    Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
    Semenzato G; Zambello R; Starkebaum G; Oshimi K; Loughran TP
    Blood; 1997 Jan; 89(1):256-60. PubMed ID: 8978299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.
    Oshimi K; Oshimi Y; Yamada O; Wada M; Hara T; Mizoguchi H
    J Immunol; 1990 May; 144(9):3312-7. PubMed ID: 2139452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of natural killer cells via the p75 interleukin 2 receptor.
    Phillips JH; Takeshita T; Sugamura K; Lanier LL
    J Exp Med; 1989 Jul; 170(1):291-6. PubMed ID: 2787381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.